UCB Pharmaceuticals SWOT Analysis, Competitors & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of UCB Pharmaceuticals analyses the brand by its strengths, weaknesses, opportunities & threats. In UCB Pharmaceuticals SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like UCB Pharmaceuticals to benchmark its business & performance as compared to the competitors. UCB Pharmaceuticals is one of the leading brands in the pharma and healthcare sector.

The article below lists the UCB Pharmaceuticals SWOT, competitors and includes its target market, segmentation, positioning & USP. Let us start the UCB Pharmaceuticals SWOT Analysis:

SWOT Analysis of UCB Pharmaceuticals

For UCB Pharmaceuticals, SWOT analysis can help the brand focus on building upon its strengths and opportunities while addressing its weaknesses as well as threats to improve its market position.

UCB Pharmaceuticals Strengths

The strengths of UCB Pharmaceuticals looks at the key aspects of its business which gives it competitive advantage in the market. Some important factors in a brand's strengths include its financial position, experienced workforce, product uniqueness & intangible assets like brand value. Below are the Strengths in the SWOT Analysis of UCB Pharmaceuticals :

1. UCB has nearly 9000 well trained employees

2. Strong global presence in over 40 countries

3. It has strong product pipeline with many molecules in last stages of development especially in case of CNS

4. They have four major blockbuster products such as Cimzia, Vimpat, Neutro, Keppra.

UCB Pharmaceuticals Weaknesses

The weaknesses of a brand are certain aspects of its business which are it can improve to increase its position further. Certain weaknesses can be defined as attributes which the company is lacking or in which the competitors are better. Here are the weaknesses in the UCB Pharmaceuticals SWOT Analysis:

1. Company operates in limited segments of medication for severe diseases only

2. It has limited presence in developing world as majority of revenue comes from America & Europe operations


UCB Pharmaceuticals Opportunities

The opportunities for any brand can include areas of improvement to increase its business. A brand's opportunities can lie in geographic expansion, product improvements, better communication etc. Following are the opportunities in UCB Pharmaceuticals SWOT Analysis:

1. There is good scope for development of new treatment options in epilepsy

2.  they can further utilize full potential of their blockbuster drugs

3. Increasing awareness about severe diseases

UCB Pharmaceuticals Threats

The threats for any business can be factors which can negatively impact its business. Some factors like increased competitor activity, changing government policies, alternate products or services etc. can be threats. The threats in the SWOT Analysis of UCB Pharmaceuticals are as mentioned:

1. Economic instability of euro zone can hurt revenue of company

2. Strong FDA drug development guidelines

3. Increasing competition of other pharma majors in their business segments


UCB Pharmaceuticals Competitors

There are several brands in the market which are competing for the same set of customers. Below are the top 4 competitors of UCB Pharmaceuticals:

1. Abbott laboratories
2. Amgen

3. AstraZeneca

4. Forest laboratories

Hence this concludes the UCB Pharmaceuticals SWOT analysis.

Continue reading more about the brand/company.

About UCB Pharmaceuticals

UCB Pharmaceuticals Overview
Parent Company

UCB Pharmaceuticals

Category

Pharmaceutical

Sector

Pharma and Healthcare

Tagline/ Slogan

Aspiring to be patient centric biopharma leader

USP

It is global biopharma focused on severe diseases with operations in over 40 countries

UCB Pharmaceuticals STP
Segmentation

Central nervous system diseases & immunology

Target Market

Healthcare professionals offering solutions to patients suffering from severe diseases

Positioning

A global biopharma focused in severe diseases focused in two areas namely CNS & immunology


This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Browse marketing analysis of more brands and companies similar to UCB Pharmaceuticals. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2500 brands from over 20 industry sectors.

Continue Reading:


The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute

Share this Page on:
Facebook ShareTweetShare on Linkedin